Bevacizumab As Maintenance Treatment in Patients With Ovarian Cancer: Wait for BRCA Testing-Reference-Cited by-同舟云学术

Bevacizumab As Maintenance Treatment in Patients With Ovarian Cancer: Wait for BRCA Testing

Published:2020-01-10 Issue:2 Volume:38 Page:172-173
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Farolfi Alberto¹,Lorusso Domenica¹,Pignata Sandro¹,De Giorgi Ugo¹

Affiliation:

1. Alberto Farolfi, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola, Italy; Domenica Lorusso, MD, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Sandro Pignata, MD, PhD, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy; and Ugo De Giorgi, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.02055

Reference9 articles.

1. Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

2. Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

3. Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

4. BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study

5. BRCA1 Plays a Role in the Hypoxic Response by Regulating HIF-1α Stability and by Modulating Vascular Endothelial Growth Factor Expression

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive comparison of medication strategies for platinum-sensitive recurrent ovarian cancer: A Bayesian network meta-analysis;Frontiers in Pharmacology;2022-11-10

2. Beyond BRCA Status: Clinical Biomarkers May Predict Therapeutic Effects of Olaparib in Platinum-Sensitive Ovarian Cancer Recurrence;Frontiers in Oncology;2021-07-29

3. Newly diagnosed ovarian cancer: Which first-line treatment?;Cancer Treatment Reviews;2020-12

4. Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study;Scientific Reports;2020-10-23

5. Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study;Gynecologic Oncology;2020-10